Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention

制定综合性、基于恢复的急性后 COVID-19 综合症 (PACS) 心理治疗干预措施

基本信息

  • 批准号:
    10586328
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-10-01 至 2024-09-30
  • 项目状态:
    已结题

项目摘要

Project Abstract At present, 34.6 million people in the United States, and 273,232 Veterans tested or treated in Veteran Affairs facilities contracted COVID-19. While the exact prevalence of Post-Acute COVID-19 Syndrome (PACS) among Veterans is unknown, estimates of psychiatric/neurological PACS using a large global sample of COVID-19 patients (N=236,379) suggest a prevalence of approximately 11,390,400 Americans, and 90,311 Veterans in VA care, with rates likely to increase over time. Moreover, large scale studies suggest up to 35% of individuals experience functional impairment 8 months after COVID-19, and high prevalence of post-infection mental illness including anxiety disorders, depression, and post-traumatic stress disorder. Using longitudinal data from our academic affiliate, Icahn School of Medicine at Mount Sinai’s COVID registry (n≈1200), and local James J. Peters VA’s Clinical PACS program, coupled with our expertise in recovery-based psychotherapy, we are uniquely poised to develop an innovative treatment for Veterans struggling with PACS. Our intervention aims to improve psychological adjustment to PACS symptoms, promote resiliency, and facilitate coping, all of which can impact functional status and quality of life. The PACS-Coping and Recovery (PACS-CR) intervention we aim to develop focuses on psychological adjustment and coping, and augments medical, rehabilitative and neurological treatment for this population. Our approach is based on the CHIME model of personal recovery which includes five overarching processes: 1) Connectedness; 2) Hope and optimism about the future; 3) Identity; 4) Meaning in life; and 5) Empowerment. We will target the CHIME processes using established psychotherapeutic techniques such as skills training, acceptance-based and identity-based principles. Based on adaptations from existing recovery-based and COVID-19 distress group interventions that our team has developed and piloted, we are proposing a treatment framework that consists of a core of twelve 90-minutes sessions (1x/week x 12 weeks) with additional weekly sessions on specialized topics that are optional. We are proposing a treatment development NIH Stage 1A study to develop a Post-Acute COVID-19 Syndrome psychotherapeutic intervention, “PACS Coping and Recovery” (PACS-CR) through an iterative development process while collecting pilot data to assess its acceptability and feasibility. Our treatment development SPiRE will focus on 1) determining the treatment needs of Veterans with PACS, 2) developing the treatment using pilot qualitative data and aided by stakeholder feedback, 3) refining the intervention by three iterative pilots of our groups, testing both in person and telehealth versions. Pre and post measures will be utilized to track functional improvement and the degree to which this recovery-focused intervention has enabled the veterans to engage in meaningful life changes.
项目摘要 目前,美国有3460万人,273,232名退伍军人在退伍军人事务部接受检测或治疗 感染COVID-19的设施。虽然急性COVID-19综合征(PACS)的确切患病率, 退伍军人是未知的,使用全球大样本的COVID-19估计精神病学/神经病学PACS 患者(N= 236,379)表明大约11,390,400名美国人和90,311名退伍军人的患病率 VA护理,随着时间的推移,利率可能会增加。此外,大规模研究表明,高达35%的人 在COVID-19后8个月出现功能障碍,感染后精神疾病患病率高 包括焦虑症抑郁症和创伤后应激障碍使用我们的纵向数据 学术分支机构,西奈山新冠肺炎登记处的伊坎医学院(n = 1200)和当地的詹姆斯·J·彼得斯(James J. Peters) VA的临床PACS计划,加上我们在恢复为基础的心理治疗的专业知识,我们是独一无二的 准备为与PACS斗争的退伍军人开发创新治疗方法。 我们的干预旨在改善对PACS症状的心理调整,促进恢复力, 应对,所有这些都可以影响功能状态和生活质量。PACS-CR(PACS-Coping and Recovery) 我们的干预目标是发展心理调整和应对的重点,并加强医疗, 康复和神经治疗。我们的方法是基于CHIME模型, 个人康复包括五个总体过程:1)连通性; 2)希望和乐观 (3)未来;(4)生命的意义;(5)权力。我们将使用 既定的心理治疗技术,如技能培训,基于接受和基于身份 原则 基于对现有基于恢复和COVID-19困境群体干预措施的调整,我们的团队 已经开发和试点,我们提出了一个治疗框架,包括12个90分钟的核心 课程(1x/周x12周),每周额外的专题课程是可选的。我们 提出一项治疗开发NIH 1A期研究,以开发急性后COVID-19综合征 心理治疗干预,“PACS应对和恢复”(PACS-CR)通过迭代开发 同时收集试点数据,以评估其可接受性和可行性。 我们的治疗开发SPiRE将专注于1)确定PACS退伍军人的治疗需求,2) 使用试点定性数据并在利益相关者反馈的帮助下制定治疗方法,3)完善 通过我们小组的三个迭代试点进行干预,在个人和远程保健版本中进行测试。前后 将采取措施跟踪功能改进情况以及这种以恢复为重点的 干预使退伍军人能够参与有意义的生活变化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marianne Goodman其他文献

Marianne Goodman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marianne Goodman', 18)}}的其他基金

Center for Harmonizing and Improving Interventions to Prevent Suicide (CHIIPS)
协调和改进预防自杀干预措施中心 (CHIIPS)
  • 批准号:
    10662785
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention
制定综合性、基于恢复的急性后 COVID-19 综合症 (PACS) 心理治疗干预措施
  • 批准号:
    10683267
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
  • 批准号:
    10425246
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
  • 批准号:
    10662374
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk for suicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
  • 批准号:
    10558287
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
  • 批准号:
    9889256
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
  • 批准号:
    10038807
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
  • 批准号:
    10594391
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
  • 批准号:
    9561655
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
  • 批准号:
    10295174
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了